Jessica Gallagher/The Baltimore Banner, for The New York Times The company’s owner, Stephen Thomas, had no significant experience providing drug treatment when he started operating the for ...

A private business has helped supercharge a controversial federal drug program. Patients and insurers have been left with big ...

Used syringes and needles lay uncapped, littered throughout a one-block stretch of the South Bronx that serves as a haven for ...

New York Times inEducation has been designed as a resource to connect Times journalism with key areas of study for students and faculty through our Education and Library Subscription Program.

Child care, housing costs and public safety were the New York governor’s top issues as she outlined her policy plans for the year and for a re-election fight in 2026. By Maya KingBenjamin ...

Here are the year’s notable fiction, poetry and nonfiction, chosen by the staff of The New York Times Book Review. In “Open Socrates,” the scholar Agnes Callard argues that the ancient Greek ...

By Corey Kilgannon A vendor with a sharp memory, puzzling behavior on the A train and more reader tales of New York City in this week’s Metropolitan Diary. The victim, the police said ...

A review of the FDA’s drug approvals of 2024 shows that small companies loomed large—both in the sheer number of nods gained and the significance of the new drugs and biologics that these ...

addressing Scotland's highest drug mortality rates in Europe. NEW DELHI: The United Kingdom (UK) will launch its first sanctioned consumption facility for illegal drugs, following prolonged ...

Caroline Gutman for The New York Times The Supreme Court on Friday grappled over a law that could determine the fate of TikTok, an enormously popular social media platform that has about 170 ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...